CM Management LLC Buys 100,000 Shares of Curis, Inc. (NASDAQ:CRIS)

CM Management LLC increased its stake in shares of Curis, Inc. (NASDAQ:CRIS) by 83.3% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 220,000 shares of the biotechnology company’s stock after purchasing an additional 100,000 shares during the period. CM Management LLC’s holdings in Curis were worth $673,000 as of its most recent SEC filing.

Separately, Focused Wealth Management Inc boosted its position in shares of Curis by 9.5% in the fourth quarter. Focused Wealth Management Inc now owns 59,204 shares of the biotechnology company’s stock valued at $181,000 after acquiring an additional 5,138 shares during the period. 29.97% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a “buy” rating and set a $20.00 target price on shares of Curis in a report on Tuesday, December 10th.

Curis Stock Down 2.0 %

Shares of NASDAQ CRIS opened at $2.91 on Friday. The stock’s 50-day simple moving average is $3.26 and its two-hundred day simple moving average is $4.19. Curis, Inc. has a twelve month low of $2.83 and a twelve month high of $17.49. The firm has a market capitalization of $24.64 million, a P/E ratio of -0.37 and a beta of 3.49.

Curis Profile

Curis, Inc, a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes.